Emergent BioSolutions (NYSE:EBS) received more than $250M in contract modifications from the Administration for Strategic Preparedness and Response at the United States Department of Health and Human ...
Source LinkEmergent BioSolutions (NYSE:EBS) received more than $250M in contract modifications from the Administration for Strategic Preparedness and Response at the United States Department of Health and Human ...
Source Link
Comments